Heron Therapeuti (HRTX)
US$ 2.29-2.55%
Price Chart
Key Statistics
Market Cap
$ 292.92M
P/E Ratio
0.00
Revenue (TTM)
$ 148.52M
Volume
705.68K
52W High
$ 3.93
52W Low
$ 1.04
Dividend Yield
0.00%
Beta
1.33
Technicals
50-Day MA
2.1602
200-Day MA
1.8735
52 Week High
3.93
52 Week Low
1.04
About HRTX
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.
Employees
122
Headquarters
Cary, NC
CEO
Mr. Craig Alexander Collard
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg